IL176762A0 - Pharmaceutical compositions comprising growth hormone and a statin - Google Patents
Pharmaceutical compositions comprising growth hormone and a statinInfo
- Publication number
- IL176762A0 IL176762A0 IL176762A IL17676206A IL176762A0 IL 176762 A0 IL176762 A0 IL 176762A0 IL 176762 A IL176762 A IL 176762A IL 17676206 A IL17676206 A IL 17676206A IL 176762 A0 IL176762 A0 IL 176762A0
- Authority
- IL
- Israel
- Prior art keywords
- statin
- pharmaceutical compositions
- growth hormone
- hormone
- growth
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54020404P | 2004-01-29 | 2004-01-29 | |
US54336604P | 2004-02-10 | 2004-02-10 | |
PCT/EP2005/000758 WO2005074916A1 (en) | 2004-01-29 | 2005-01-26 | Methods and compositions for the treatment of lipodystrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
IL176762A0 true IL176762A0 (en) | 2006-10-31 |
Family
ID=34841102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL176762A IL176762A0 (en) | 2004-01-29 | 2006-07-10 | Pharmaceutical compositions comprising growth hormone and a statin |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1722778A1 (ko) |
JP (1) | JP2007519669A (ko) |
KR (1) | KR20060127977A (ko) |
AU (1) | AU2005210093A1 (ko) |
BR (1) | BRPI0507302A (ko) |
CA (1) | CA2552404A1 (ko) |
EA (1) | EA200601392A1 (ko) |
IL (1) | IL176762A0 (ko) |
NO (1) | NO20063279L (ko) |
WO (1) | WO2005074916A1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2903312B1 (fr) | 2006-07-05 | 2008-09-26 | Univ Aix Marseille Ii | Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament |
US20110046091A1 (en) * | 2008-01-03 | 2011-02-24 | Universite De La Medierannee, Aix-Marseille Ii Jardin Du Pharo 58, Boulevard Charles Livon | Composition and methods used during anti-hiv treatment |
US20100267636A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechnologies Inc. | Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy |
US20170065678A1 (en) * | 2014-03-11 | 2017-03-09 | Novartis Ag | Methods of treating metabolic disorders associated with lipodystrophies and defects in insulin production or signaling |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9803623D0 (sv) * | 1998-10-22 | 1998-10-22 | Sahltech Ab | New therapeutic application |
-
2005
- 2005-01-26 EA EA200601392A patent/EA200601392A1/ru unknown
- 2005-01-26 CA CA002552404A patent/CA2552404A1/en not_active Abandoned
- 2005-01-26 JP JP2006550092A patent/JP2007519669A/ja active Pending
- 2005-01-26 EP EP05707019A patent/EP1722778A1/en not_active Withdrawn
- 2005-01-26 KR KR1020067016376A patent/KR20060127977A/ko not_active Application Discontinuation
- 2005-01-26 BR BRPI0507302-2A patent/BRPI0507302A/pt not_active IP Right Cessation
- 2005-01-26 AU AU2005210093A patent/AU2005210093A1/en not_active Abandoned
- 2005-01-26 WO PCT/EP2005/000758 patent/WO2005074916A1/en active Application Filing
-
2006
- 2006-07-10 IL IL176762A patent/IL176762A0/en unknown
- 2006-07-14 NO NO20063279A patent/NO20063279L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20063279L (no) | 2006-09-19 |
EA200601392A1 (ru) | 2006-12-29 |
KR20060127977A (ko) | 2006-12-13 |
EP1722778A1 (en) | 2006-11-22 |
CA2552404A1 (en) | 2005-08-18 |
WO2005074916A1 (en) | 2005-08-18 |
JP2007519669A (ja) | 2007-07-19 |
BRPI0507302A (pt) | 2007-06-26 |
AU2005210093A1 (en) | 2005-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0413730D0 (en) | A pharmaceutical composition and its use | |
IL179795A0 (en) | A pharmaceutical composition and its use | |
ZA200606229B (en) | A pharmaceutical composition | |
AU2003291103A8 (en) | Pharmaceutical composition | |
IL177480A0 (en) | Pharmaceutical composition | |
IL183986A0 (en) | Pharmaceutical compounds and compositions | |
IL164547A0 (en) | Pharmaceutical composition | |
IL178067A0 (en) | Pharmaceutical dosage forms and compositions | |
AU2003250372A8 (en) | Pharmaceutical composition | |
EP1496913A4 (en) | NEUROPROTECTIVE PHARMACEUTICAL SPIROSTENOL COMPOSITIONS | |
GB2391809B (en) | Pharmaceutical composition comprising honey | |
ZA200701527B (en) | Composition comprising statin | |
EP1765373A4 (en) | OZONIZED PHARMACEUTICAL COMPOSITION AND METHOD THEREOF | |
PL1802329T3 (pl) | Formulacja farmaceutyczna zawierająca krystaliczną insulinę oraz rozpuszczoną insulinę | |
ZA200704926B (en) | Modified human growth hormone | |
IL176762A0 (en) | Pharmaceutical compositions comprising growth hormone and a statin | |
HU0401177D0 (en) | Pharmaceutical composition | |
GB2411355B (en) | Pharmaceutical composition | |
GB0400452D0 (en) | A pharmaceutical composition | |
ZA200701932B (en) | Pharmaceutical composition | |
GB0425255D0 (en) | Pharmaceutical composition | |
HK1065477A1 (en) | Pharmaceutical composition | |
ZA200701931B (en) | Pharmaceutical composition | |
GB0406014D0 (en) | Pharmaceutical composition and use | |
GB0217703D0 (en) | Pharmaceutical composition |